Omega Healthcare Investors's revenue per share for the
three
months ended in Mar. 2026 was R$5.36.
Omega Healthcare Investors's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was R$21.51.
During the past 12 months, the average Revenue Per Share Growth Rate of Omega Healthcare Investors was 2.80% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 2.80% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -0.40% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was -1.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Omega Healthcare Investors's Revenue per Share or its related term are showing as below:
BSP:O2HI34'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -45.6 Med: 3.5 Max: 61.2
Current: 2.8
During the past 13 years, Omega Healthcare Investors's highest 3-Year average Revenue Per Share Growth Rate was 61.20% per year. The lowest was -45.60% per year. And the median was 3.50% per year.
BSP:O2HI34's 3-Year Revenue Growth Rate is ranked worse than 51.43% of 807
companies
in the REITs industry
Industry Median: 3
vs BSP:O2HI34: 2.80
Omega Healthcare Investors (BSP:O2HI34) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Omega Healthcare Investors Revenue per Share Related Terms
Omega Healthcare Investors Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Healthcare Investors Revenue per Share Chart
BSP:O2HI34 vs DOC, AHR, CTRE: Revenue per Share Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors PS Ratio vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's PS Ratio distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's PS Ratio falls into.
Omega Healthcare Investors Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Omega Healthcare Investors's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$21.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Healthcare Investors (BSP:O2HI34) has a Revenue per Share of R$21.51 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Omega Healthcare Investors and its competitors. According to the industry distribution chart, Omega Healthcare Investors ranks #415 out of 807 companies in the REITs industry, placing it in the top 51.4%.
Is Omega Healthcare Investors' Revenue per Share too high?
Omega Healthcare Investors' current Revenue per Share is R$21.51. Based on the distribution chart, Omega Healthcare Investors ranks #415 out of 807 companies in the REITs industry, which is below the industry midpoint. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Revenue per Share compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #415 out of 807 companies for Revenue per Share. This places Omega Healthcare Investors in the lower half of its industry. The industry median Revenue per Share is 3.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a REITs company?
The median Revenue per Share among REITs companies is 3.00, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median Revenue per Share is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current Revenue per Share is R$21.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Revenue per Share is R$21.51. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Revenue per Share is R$21.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
Revenue per Share: R$21.51
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
